LMAT
LMAT
NASDAQ · Health Care

Lemaitre Vascular Inc

$81.11
-2.38 (-2.85%)
As of Nov 7, 1:42 AM ET ·
Financial Highlights (FY 2026)
Revenue
256.26M
Net Income
59.27M
Gross Margin
71.5%
Profit Margin
23.1%
Rev Growth
+15.6%
D/E Ratio
0.43
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 71.5% 71.5% 55.1% 55.1%
Operating Margin 27.2% 24.5% 15.7% 15.2%
Profit Margin 23.1% 22.0% 12.7% 14.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 256.26M 221.73M 688.78M 823.96M
Gross Profit 183.30M 158.61M 379.66M 454.17M
Operating Income 69.73M 54.30M 108.14M 124.98M
Net Income 59.27M 46.16M 87.65M 120.31M
Gross Margin 71.5% 71.5% 55.1% 55.1%
Operating Margin 27.2% 24.5% 15.7% 15.2%
Profit Margin 23.1% 22.0% 12.7% 14.6%
Rev Growth +15.6% +15.6% +17.5% -8.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 286.42M 286.42M 832.61M 742.63M
Total Equity 668.26M 668.26M 1.10B 1.03B
D/E Ratio 0.43 0.43 0.76 0.72
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 75.52M 62.08M 151.37M 185.12M
Free Cash Flow — — 80.37M 83.71M